[Can we avoid axillary lymph node dissection in patients with node positive invasive breast carcinoma?].
Fiche publication
Date publication
janvier 2024
Journal
Gynecologie, obstetrique, fertilite & senologie
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MATHELIN Carole
Tous les auteurs :
Brousse S, Lafond C, Schmitt M, Guillermet S, Molière S, Mathelin C
Lien Pubmed
Résumé
The indications and modalities of breast and axillary surgery are undergoing profound change, with the aim of personalizing surgical management while avoiding over-treatment. To update best practices for axillary surgery, four questions were selected by the Senology Commission of the Collège National des Gynécologues et Obstétriciens Français (CNGOF), focusing on 1) the definition and evaluation of targeted axillary dissection (TAD) techniques, 2) the possibility of surgical de-escalation in case of initial lymph node involvement while performing initial surgery, 3) in case of surgery following neo-adjuvant systemic therapy (NAST), 4) contraindications to de-escalation of axillary surgery to allow access to particular adjuvant systemic therapies.
Mots clés
axillary lymph node dissection, breast cancer, cancer du sein, chirurgie, curage axillaire, dissection axillaire ciblée, ganglion sentinelle, sentinel lymph node, surgery, targeted axillary dissection
Référence
Gynecol Obstet Fertil Senol. 2024 01 6;: